BOSTON, May 21, 2026 /PRNewswire/ -- Outcomes4Me Inc., the leading direct-to-patient health technology company leveraging AI to revolutionize cancer care, today announced it has completed its acquisitions of two innovative platforms: Geno.Me, a platform that bridges the gap between...
Hence then, the article about outcomes4me acquires geno me and realyze intelligence names upmc hillman cancer center cio as strategic advisor to expedite ai driven cancer care and clinical trial access was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Outcomes4Me Acquires Geno.Me and Realyze Intelligence, Names UPMC Hillman Cancer Center CIO as Strategic Advisor, to Expedite AI-driven Cancer Care and Clinical Trial Access )
Also on site :
- British Columbia Retains California-Based Stranch, Jennings & Garvey to Challenge OpenAI Over Corporate Silence
- Active Motif annonce la signature d'un accord exclusif de distribution mondiale avec Arima Genomics pour des solutions génomiques 3D de pointe
- PerkinElmer and Covalent Announce Strategic Collaboration to Advance Failure Analysis and Materials Characterization for Semiconductor, Electronics, and Battery Industries